GL
GLAXO.KAR GlaxoSmithKline Pakistan Ltd
326.01 PKR
Close of Oct 29, 2026
278.20
427.72
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is GLAXO.KAR undervalued?
Graham numberThe Graham number of GlaxoSmithKline Pakistan Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
GlaxoSmithKline Pakistan Ltd fundamental analysis
No fundamental analysis for GlaxoSmithKline Pakistan Ltd yet.
GlaxoSmithKline Pakistan Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of GlaxoSmithKline Pakistan Ltd are not available yet.
GlaxoSmithKline Pakistan Ltd dividends
GlaxoSmithKline Pakistan Ltd has not paid dividends in the last 1 fiscal years.
Who owns GlaxoSmithKline Pakistan Ltd
Ownership data of GlaxoSmithKline Pakistan Ltd is not available yet.
GlaxoSmithKline Pakistan Ltd company profile
- Company name
- GlaxoSmithKline Pakistan Ltd
- Ticker
- GLAXO.KAR
- ISIN
- PK0001301016
- Exchange
- Karachi Stock Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Address
- Website
- -